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ABSTRACT
Three simple and sensitive spectrophotometric methods are described for determination of ritodrine hydrochloride (RTH) either
in pure form or dosage forms. The first method was based on the reaction with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl)
in borate buffer of pH 8.0 producing a yellow colored product measured at 392 nm. The second and third methods were based on
RTH oxidation with either 1,10-phenanthroline or Folin-Ciocalteu reagents producing red and blue chromogens which were measured
at 510 and 760 nm, respectively. Beer’s law was obeyed in the ranges of, 2-16, 0.2-2, 0.8-12 µg/mL with the minimum detectable
values of 0.1, 0.05, 0.14 µg/mL for the three methods, respectively. Different experimental parameters affecting the development and
stability of colored products were carefully studied and optimized. The effect of different foreign matters and sensitizers on the color
development in the three proposed methods was also studied. The proposed methods were successfully applied to the determination
of RTH in its dosage forms. The obtained percentage recoveries were 99.73 ± 0.72, 99.88 ± 1.2, 99.97 ± 0.42 for the three proposed
methods, respectively. The obtained results were statistically validated and compared with those obtained with a reference method.
Proposals of the reactions mechanisms were presented.
Key words: ritdorine HCl, spectrophotometry, NBD-Cl, 1,10-phenanthroline, Folin-Ciocalteu, dosage forms

INTRODUCTION
Ritodrine hydrochloride (RTH), erythro-1-( phydroxyphenyl)-2-(4-hydroxyphenethylamino) propan1-ol hydrochloride is a β2 adrenergic agonist solely used
as uterine relaxant (1)(Figure 1). RTH is a direct-acting
sympathomimetic agent with predominantly β-adrenergic
activity and selective action on β2 receptors. It decreases
uterine contractility and is used to arrest premature labor
and to alleviate fetal asphyxia during labor in case of
emergency(2). The British pharmacopoeia (1) recommended a HPLC method for its assay either in raw materials or
pharmaceutical preparations.
The literature is enriched with several methods for
determination of RTH in pharmaceutical dosage forms
including UV spectrophotometry (3), sequential injection
spectrophotometry(4), colorimetry(5-12), and spectrofluorometry(12). Meanwhile, the assay of RTH in biological
samples has been reported using HPLC(13-15) and GCMS(16,17) methods. The therapeutic importance of RTH
required the development of sensitive, simple and reliable
methods for industrial quality control of its pharmaceutical preparations. Some of the reported methods for RTH
* Author for correspondence. Tel: +20502247496;
Fax: +20502247496; E-mail: dina_elsherbiny@mans.edu.eg

determination are either laborious (13-17) or insufficiently
sensitive (3,5,8-10). In the present work three simple and
sensitive colorimetric methods have been developed and
validated for this purpose. The three methods are based
on the reaction with 4-chloro-7-nitrobenzo-2-oxa-1,3diazole (NBD-Cl) (method 1) or application of the oxidation of ritodrine with either Fe(ΙΙΙ)-1,10-phenanthroline
(FPL) (method 2) and Folin-Ciocalteu (F-C) (method 3).
NBD-Cl is a labeling reagent specific for primary and secondary amines. Several pharmaceutical
compounds have been determined through this approach,
such as skeletal muscle relaxant and antihistaminic
drugs(18), oxicams (19), trimetazidine (20), lisinopril(21),
fenoterol(22), β-blockers(23) and tramadol(24).
1,10-Phenanthroline (FPL) is an oxidizing agent
for many drugs with reducing properties particularly
H OH
H
N

HO

H CH3

Figure 1. Structural formula of ritodrine hydrochloride.
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phenolic compounds, in which dark red orange chelate is
formed. This reaction was used in the determination of
many drug substances such as ascorbic acid(25), amlodipine (26), amoxycillin, ciprofloxacin and piroxicam(27), and
acetaminophen(28).
Folin-Ciocalteu reagent (F-C) is specially used for
the determination of many phenolic compounds utilizing its liability to be reduced into blue colored product.
Many drug substances such as salbutamol(29), minocycline (30), diclofenac (31), trimetazidine (32), acyclovir (33),
methotrexate (34), omeprazole (35), sulphinpyrazone (36),
and gliclazide (37), have been determined on this basis.
The structural features of RTH allowed the use of the
three reagents for its assay. The three proposed methods
have been successfully applied to the assay of RTH in
pharmaceutical dosage forms.

MATERIALS AND METHODS
I. Materials and Reagents

III. Sample Preparation and Procedure
Standard solution of RTH containing 100 µg/mL was
prepared in distilled water and was further diluted with
the same solvent as appropriate. The standard solution
was kept in the refrigerator and was found to be stable for
at least 7 days.
IV. Construction of Calibration Graph for Method 1
Increasing volumes from the stock solution of the
drug were quantitatively transferred to a set of 10-mL
volumetric flasks, so as to contain the drug within the
concentration range 2.0-16 µg/mL. Borate buffer (3.5
mL) of pH 8 followed by 1.0 ± 0.2 mL of NBD-Cl solution (0.05%) were added to each flask. The solutions were
heated for 15 min at 70°C. The reaction was quenched by
cooling under tap water, and then 0.2 mL of concentrated
HCl was added and each flask was made up to volume
with distilled water. The absorbance was measured at
392 nm against a reagent blank.

All materials and reagents used were of analytical
reagent grade. Ritodrine hydrochloride (RTH) reference
standard was kindly provided by Solvay Duphar (The
Netherlands). Pharmaceutical preparations containing
RTH, Yutopar tablets labeled to contain 10 mg RTH per
tablet and Yutopar ampoules labeled to contain 10 mg
RTH per 1 mL of ampoule, were purchased from a local
pharmacy.
4-Chloro-7-nitrobenzo-2-oxa-1,3-diazole reagent (NBD-Cl)
(Sigma, St. Louis, USA) was prepared as 0.05% (w/v) ethanolic solution.
Ferric phenanthroline reagent (FPL) was prepared by mixing
0.193 gm of the 1,10-phenanthroline (Sigma-Aldrich, St.
Louis, USA) with 2 mL of 1.0 M HCl and 0.16 gm of ferric
ammonium sulfate dodecahydrate (Sigma, St. Louis, USA)
and diluted with distilled water to 100 mL(27).
Folin-Ciocalteu reagent (F-C) (2.0 N solution) (Sigma
Aldrich, Buchs, Switzerland)
Hydrochloric acid (Prolabo, France)
Borate buffer, 0.2 M (pH 8.0)
10% Na2CO3 (w/v) solution was prepared in distilled water.
Sodium dodecyl sulfate (SDS), 99% purity (Park Scientific
Ltd, Northampton, UK)
Sodium dioctyl sulfosuccinate (SDOSS), (UNIKEM,
Copenhagen, Denmark). Cetyltrimethyl ammonium
bromide (Cetrimide), (Merck, Darmstadt, Germany)
Polyoxyethylene 23-lauryl ether (Brij 35). (Sigma, St. Louis,
MO, USA)
3-N,N-dimethylmyristyl ammonium propane sulfonate
(MAPS), (Fluka AG, Buchs, Switzerland).

V. Construction of Calibration Graph for Method 2

II. Apparatus

For Yutopar tablets, 10 tablets were finely powdered
after weighing. A portion of the tablet powder equivalent
to 10 mg of the drug was extracted with 3 × 30 mL portions
of distilled water. After sonication of each portion for 10

A Shimadzu UV-Visible 1601 PC spectrophotometer
was used for the spectrophotometric measurements.

To a set of 10-mL volumetric flasks, increasing
volumes from the stock solution of the drug were quantitatively transferred so as to contain the drug within
the concentration range 0.2-2 µg/mL. To each flask 2.5
± 0.2 mL of FPL was added. The solutions were heated
in a boiling water bath for 20 min. The reaction was
quenched by cooling under tap water and each flask was
made up to volume with distilled water. The absorbance
was measured at 510 nm against a reagent blank.
VI. Construction of Calibration Graph for Method 3
Increasing volumes from the stock solution of the
drug were quantitatively transferred to a set of 10-mL
volumetric flasks, so as to contain the drug within the
concentration range 0.8-12 µg/mL. Five milliliter of
Na 2CO3 solution (10% w/v) followed by 0.75 ± 0.2 mL of
F-C solution (2N) were added to each flask. The solutions were stored for 20 min at ambient temperature then
each flask was made up to volume with distilled water.
The absorbance was measured at 760 nm against a
reagent blank.
The calibration curves for the three proposed methods were constructed by plotting the absorbance against
the final concentration of the drug. Alternatively, the
corresponding regression equations were derived.
VII. Analysis of the Pharmaceutical Formulations
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RESULTS AND DISCUSSION

was found to be stable for at least 2 hr.
The effect of diluting solvents other than water such
as acetone, acetonitrile, methanol, ethanol and dimethyl formamide (DMF) was also investigated to obtain

0.600

(c)
(b)
0.400

(a)

Abs.

min, the extracts were transferred quantitatively into 100
mL measuring flasks and the flask was made up to volume
with distilled water. The final solution was centrifuged
(4000 ×g) for 15 min, and filtered. For Yutopar ampoules,
the contents of five ampoules were mixed, and 1 mL
volume of the mixture which equivalent to 10 mg of the
drug was transferred into 100-mL volumetric flask. Afterwards, the flask was made up to volume with distilled
water after mixing well. The final solution was used without filtration. For both prepared solutions of tablets and
ampoules, further dilutions were made as appropriate with
distilled water and processed as described under Construction of calibration graphs, adopting the three different
proposed methods. The nominal content of the tablets
and ampoules were calculated using either the calibration
graph or the corresponding regression equation.

I. Method 1
0.200

0.000
330.0

600.0

800.0

1000.0

Wavelength (nm.)

Figure 2. Absorption spectra of reaction products of RTH with (A)
0.05% NBD-Cl in borate buffer of pH 8.0 (16 µg/mL), (B) 0.01 M
FPL in acidic medium (2 µg/mL), and (C) 2.0 N Folin-Ciocalteu in
Na2CO3 solution (6 µg/mL).

0.3
0.25

Absorbance (1cm)

The reaction between NBD- Cl and the secondary
amino group of RTH in borate buffer of pH 8.0 was found
to produce a yellow colored product with a maximum
absorbance at 392 nm (Figure 2A). The different experimental parameters affecting the intensity of the produced
color were studied and optimized to obtain the maximum
color intensity.
The pH was varied over the pH range of 7-10 using
borate buffer where the maximum absorbance was
obtained at pH 8.0 as shown in Figure 3. The effect of
using different buffer solutions such as carbonate or
phosphate buffers as alternatives to borate buffer at this
optimum pH value was also investigated. It was found
that borate buffer is superior in obtaining the maximum absorbance. This may be attributed to hydrolysis
of the reagent with other buffers, as revealed in previous reports (22). NBD-Cl is also hydrolyzed in alkaline
medium to give NBD-OH which has a maximum absorbance at 462 nm. Therefore, it was necessary to acidify the reaction mixture to pH 2 (by adding 0.2 mL of
concentrated HCl) before measurement. At this acidic
pH, the reagent blank did not show any significant
absorption peak.
The effect of temperature on the color intensity was
studied by heating the reaction mixture over the range
from 50 to 100°C for different periods of time. It was
found that heating at relatively lower temperature (70°C)
for 15 min gave more reproducible results as illustrated
in Table 1.
The effect of different volumes of 0.05% NBD-Cl on
the color intensity was studied over the range 0.2 to 1.6
mL. It was found that 1.2 ± 0.2 mL was the most suitable
volume of the reagent (Table 1). These optimum conditions have been used for the proposed spectrophotometric method. As for stability of the produced derivative, it

0.2
0.15
0.1
0.05
0

5

6

7

8

9

10

pH

Figure 3. Effect of pH of borate buffer (0.2 M) on development of the
reaction product of RTH (10 µg/mL) with NBD-Cl.
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Stoichiometry of the Reaction
The stoichiometry of the reaction was studied using
equimolar concentrations of the drug and NBD-Cl adopting Job’s method of continuous variation(38), a molar
ratio of 1:1 (drug: NBD-Cl) respectively, was obtained by
the applied method as shown in Figure 4. Based on the
observed molar reactivity of the reaction, the mechanism
of the reaction between RTH and NBD-Cl was postulated
in Scheme 1.
The formation constant of the reaction product Kf
was calculated using the following formula (39):
K

f

=

1.8
1.6

Absorbance (1cm)

the maximum color intensity. It was found that water,
acetone and acetonitrile are of similar effect. Meanwhile, ethanol, methanol and DMF slightly decreased the
color intensity.
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Table 1. Factors affecting formation of the reaction product of
ritodrine (10 µg/mL) with NBD-Cl
Heating Temperature (°C)

0.8

O2N

H Me

HO

Absorbance

0.6

Figure 4. Determination of molar reactivity of NBD-Cl - RTH using
Job’s method of continuous variation (0.005 M).

n +1

where A is the maximum absorbance of the continuous variation curve (Figure 4), Am is the absorbance correspond-

0.4

Mole ratio [ritodrinel]/[ritodrinel]+[NBD-Cl]

A /A m
¥1-A ´
¦
µ
§ Am ¶

1.4

N
O
N

HO H
N
HO

H Me

+ HCl
OH

Scheme 1. Proposal of the reaction mechanism between ritodrine and
NBD-Cl.

ing to intersection of the two tangents of the continuous
variation curve, C is the molar concentration of RTH corresponding to maximum absorbance, n is the number of the
molecules of the reagent in the reaction product, and Kf was
found to be equal to 3695. This high value of Kf indicates a
very stable reaction product.
The Gibbs free energy of the reaction ΔG was also
calculated with the following equation:
ΔG = -2.303RT log Kf
where R is the universal gas constant (8.314 J), T is
the absolute temperature (273 + 25°C) and Kf is formation constant of the reaction.
The value of ΔG was found to be (-20.36) K.J/mole.
The negative sign of ΔG points out to the spontaneous
nature of the reaction.
II. Method 2
Ferric salts play a prominent role in the spectrophotometric determination of many pharmaceutical
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drug substances acting as an oxidant. The Fe3+/l,10phenanthroline (Fe3+/phen) system is a valuable reagent
for analytes with reducing properties, because the final
product is the intensely colored and extractable chelate
[Fe(phen)3]2+ (27). RTH as a phenolic compound can
undergo oxidation by FPL reagent in a weakly acidic
medium, forming an orange red colored complex with
absorption maximum at 510 nm. Absorption spectrum of
this colored complex is shown in Figure 2B. The optimum reaction parameters were established via number of
preliminary experiments.
The color intensity of the formed complex
[Fe(phen)3]2+ was measured against different concentrations of the reagent ranged from 0.25 to 3.0 mL. As
shown in Figure 5, reagent ranging from 1.5 to 3.0 mL
gave the maximum absorbance values. Hence 2.5 mL of
the reagent was used through out this study.
The formation of colored complex was slow at room
temperature and required longer time for maximization
because of kinetic hindrance. The reaction was accel-

Absorbance (1cm)

0.25

erated by heating for 20 min, at higher temperature of
40°C to 100°C using thermostatically controlled water
bath. It was observed that the maximum absorbance was
obtained upon boiling. Different boiling times were then
further investigated over time intervals ranged from 5
to 30 min. The maximum color intensity was obtained
after boiling the reaction mixture for 15 min, thus boiling for 20 min was chosen as an optimum boiling time to
assure complete reaction. The absorbance of the resulting colored product was stable at the room temperature
for more than 24 hours.
The stoichiometry of the reaction was studied adopting the limiting logarithmic method (40). The two straight
lines obtained upon using increasing concentrations of
the drug while keeping the concentration of the reagent
constant (Figure 6A) and upon using increasing concentrations of the reagent while keeping the concentration of
the drug constant (Figure 6B). The two lines gave two
slopes with the values of 0.224 and 1.001 for RTH and
FPL, respectively, therefore the molar ratio for the reaction between RTH and FPL, is approximately 1:4. Based
on the observed molar ratio, the reaction pathway shown
in scheme 2 is proposed.

OH H
N

0.2

H2O

+ 4Fe+3
OH

CH3

HO

OH H
N

0.15

+ 4Fe+2 +2H+

CH3

O

O
++

0.1

4 Fe

4Fe+2 + 12
0

0.5

1

1.5

2

2.5

3
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Figure 5. Ef fect of dif ferent volu mes of 0.01 M FPL on the
development reaction product with RTH (1 µg/mL).
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N N
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3

Scheme 2. Proposal of the reaction mechanism between ritodrine and
1,10-phenanthroline.
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Figure 6. Limiting logarithmic plots for the molar reactivity of RTH with FPL: (A) log A vs. log [RTH] with [1,10PHT] kept at 1.5 × 10 -3 M;
(B) log A vs. log [1,10PHT] with [RTH] kept constant at 3.1 × 10 -6 M.
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This method is based on formation of blue colored
chromogen, following the reduction of phosphor-molybdo
tungestic mixed acid of the Folin-Ciocalteu reagent (FC) by RTH in the presence of sodium carbonate, which
could be measured at 760 nm as shown in Figure 2C. The
mixed acids in the F-C reagent are the final chromogen and
involve the following chemical species: 3H 2O·P2O5·13WO3
·5MoO3·10H 2O and 3H 2O·P2O5·14WO3·4MoO3·10H 2O.
RTH probably affects the reduction of 1, 2 or 3
oxygen atoms from tungestate and/or molybdate in F-C
reagent, thereby producing one or more possible reduced
species with characteristic intense blue color. The effect
of different variables such as volume of F-C reagent,
selection of the reaction medium, optimum volume of
Na 2CO3, and reaction time were studied and optimized
for attainment of maximum color intensity and stability.
The influence of F–C reagent concentration on the
color development was investigated and the obtained
results are shown in Figure 7. It is apparent that 0.5 to
1.0 mL of reagent gave the maximum color intensity, thus
0.75 mL of reagent was used throughout the work.
To find a suitable medium for the reaction, different aqueous bases were investigated, such as sodium
hydroxide, sodium carbonate, sodium acetate and sodium
hydrogen phosphate. The maximum color intensity was
obtained upon using sodium carbonate. The optimum
concentration of sodium carbonate solution was further
investigated. After different volumes of 10% sodium

carbonate solution were attempted at a constant concentration of RTH (8 µg/mL), it was found that different
volumes ranged from 4.0 to 6.0 mL were optimum thus
5.0 mL was used throughout the work.
Development of the colored reaction product was
not instantaneous. Maximum color development was
obtained within 15 min of mixing the reactants, and was
stable for at least 30 min thereafter.
IV. Effect of Foreign Matters and Different Surfactants
The effect of different surfactants and foreign
0.7

Absorbance (1cm)

III. Method 3

0.6
0.5
0.4
0.3
0.2
0

0.5

1

1.5

2

Volume of 2.0 N F-C reagent (mL)

Figure 7. Effect of different volumes of (2.0 N) F-C reagent on the
development of the reaction product with RTH (8 µg/mL) in Na2CO3
solution.

Table 2. Effect of foreign substances and different surfactants on performance of the three proposed methods for determination of ritodrine
HCl

Concentration of ritodrine HCl (µg/mL)

Method 1

Method 2

Method 3

10

1.5

8

Absorbance
With out foreign substances or surfactant
Concentration of foreign substances (µg/mL)

0.33

0.24

0.60

10

5

1

10

5

1

10

5

1

Glucose

0.18

0.19

0.20

0.33

0.33

0.33

0.60

0.60

0.61

Lactose

0.22

0.23

0.24

0.34

0.34

0.35

0.60

0.60

0.60

Sucrose

0.17

0.18

0.23

0.32

0.32

0.33

0.60

0.60

0.60

Starch

0.16

0.18

0.24

0.33

0.33

0.33

0.60

0.60

0.61

15

10

5

15

10

5

15

10

5

Sodium dodecyl sulfate

0.19

0.24

0.25

0.34

0.34

0.34

0.61

0.61

0.61

Cetrimide

0.14

0.22

0.22

0.33

0.33

0.33

0.61

0.61

0.6

Brij 35 (polyoxyethylene 23 lauryl ether )

0.15

0.18

0.25

0.33

0.33

0.33

0.58

0.58

0.60

Sodium dioctyl sulfosuccinate

0.23

0.26

0.25

0.32

0.32

0.33

0.58

0.58

0.60

3(N,N-Dimethylmyristylammonio)
propanesulfonate

0.17

0.22

0.25

0.32

0.33

0.34

0.58

0.58

0.60

Concentration of surfactant (µg/mL)
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Table 3. Application of the three proposed spectrophotometric methods for determination of RTH in dosage forms
Recovery, % ± SDa
Proposed methods

Sample

Yutopar tabletb
(10 mg rito drine HCl/tab)
Yutopar ampouleb
(10 mg rito drine HCl/amp)

Reference method

Method 1

Method 2

Method 3

102.28 ± 0.13

100.21 ± 0.42

99.94 ± 0.46

t = 2.29 (2.776)

1.98 (2.776)

2.36 (2.571)

F = 1.49 (9.28)

6.89 (9.28)

8.27 (9.12)

99.99 ± 0.37

100.14 ± 0.35

100.18 ± 0.25

t = 0.05 (2.776)

1.05 (2.571)

1.36 (2.571)

F = 3.79 (9.28)

3.39 (9.12)

1.73 (9.12)

101.00 ± 0.16

100.00 ± 0.19

a

Mean recovery of 3 separate determinations.
The figure in parenthesis are the tabulated values of t and F at p =/0.05.
b
Products of Pharco pharmaceutical, Alexandria, Egypt.

substances on the development of the colored products in the three proposed methods was investigated by
adding three different concentrations of each substance
to the reaction mixture. The investigated surfactants are
either anionic such as sodium dodecyl sulfate (SDS) and
sodium dioctyl sulfosuccinate (SDOSS), cationic such as
cetrimide (CTR), or nonionic such as polyoxyethylene 23
lauryl ether (Brij 35) and 3(N,N-dimethylmyristylammonio propanesulfonate) (MAPS). The foreign substances included glucose, lactose, sucrose and starch. The
obtained results are illustrated in Table 2. It was found
that some of the tested substances had slight diminishing
effect on absorbance of the developed colored reaction
product with NBD-Cl (method 1). However, this effect
increased upon increasing the concentration of the tested
substances. Meanwhile, methods 2 & 3 were more resistant to this effect even at higher concentrations of the
investigated substances.
V. Assay of Dosage Forms
Applicability of the three proposed methods was
tested by determination of RTH in its dosage forms Yutopar
tablets and Yutopar ampoules. Excellent recoveries and
SD values were obtained (Table 3). Common tablet excipients, such as lactose, starch, talc, starch, avisil, gelatin,
and magnesium stearate, did not interfere with the assay in
the three applied methods. However, the slight diminishing effect of either lactose or starch on the absorbance of
the reaction product of method 1 (Table 2) did not affect
the percent recoveries of the tablets due to either its presence at low tolerable concentration (lactose) or its insolubility in water where the tablets were extracted (starch).
A previously reported spectrophotometric method(5) was
used for comparison using Student’s t-test and the variance
ratio F-test. As illustrated in Table 3, the calculated values
did not exceed the reference figures indicating lack of
significant difference in the performance of the compared
methods regarding accuracy and precision(41).

Table 4. Analytical parameters for the assay of ritodrine adopting
the three proposed spectrophotometric methods
Parameter

Method 1

Method 2

Method 3

λmax (nm)

392

510

760

Linearity range ( µg/mL)

2-16

0.2-2.0

0.8-12

7.9 × 103

7 × 104

2.4 × 104

8.08 ×10-4

7.3 ×10-4

-1.8 ×10-3

0.02

0.22

0.07

Apparent molar
absorptivity
(L/mol/cm)
Linear regression
Intercept (a)
Slope (b)
Correlation coefficient (r)

0.9999

0.9999
-4

0.9999
-3

Sy/x

9.30 × 10

2.55 × 10

2.00 × 10-3

Sa

7.20 × 10-4

3.51 × 10-3

3.02 × 10-3

Sb

7.17 × 10-5

1.56 × 10-3

3.10 × 10-4

LOD (μg/mL)

0.10

0.05

0.14

LOQ (μg/mL)

0.30

0.16

0.41

RSD (%)

0.72

1.21

0.42

Er (%)

0.25

0.50

0.17

Sy/x: standard deviation of the residuals; Sa: standard deviation of
the intercept of regression line; Sb: standard deviation of the slope of
regression line; RSD % = (%)/√n; Er % = error (%).

VI. Validation
The three proposed methods were validated based
on sensitivity, linearity, intraday and interday precision,
accuracy, specificity, and robustness.
Sensitivity of the three methods was evaluated by
determining the limit of detection (LOD) and limit of
quantitation (LOQ) according to the ICH guidelines (ICH
Topic Q2B; (42)).
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LOD was defined as:

sion was assessed by determination of each concentration
on three separate days. Repeatability and reproducibility
in the three proposed methods were fairly good, as indicated by the small values of standard deviation (SD), relative standard deviation (RSD), and error (%Er) (Table 5).
Specificity of the three methods was proven by the
negligible effect of the presence foreign matters and
different surfactants on the absorbance intensity.
Robustness of the three methods is demonstrated by
the consistency of the absorbance intensity with minor
changes in experimental variables, such as changing pH
(method 1), changing heating times (methods 1 and 2),
changing the reaction times (method 3), molar concentration of the buffer (method 1) and reagent volume (methods 1, 2 and 3). The minor changes expected to take
place during the course of the operation of the method
did not adversely affect the absorbance intensity.

3.3 × σ/S
and LOQ was:
10 × σ/S
where σ is standard deviation of the y-intercept of the
regression lines (the standard deviation of the response) and
S is slope of the calibration curve.
Linearity was evaluated by calculation of the regression equations over the ranges given in Table 4. The table
also shows the detection limits, slopes, intercepts, and
correlation coefficients obtained by linear least squares
treatment of the results, standard deviation of slopes (Sb)
and intercepts (Sa) on the ordinates, and standard deviation of the residuals (Sy/x)(41).
The intraday and interday accuracy and precision for
the three proposed methods were examined by analysis
of samples of RTH in its dosage forms in two different
concentrations. Intraday precision was assessed by five
determinations/concentration in one day. Interday preci-

CONCLUSIONS
Three simple and sensitive spectrophotometric
methods were developed for the determination of RTH.

Table 5. Accuracy and precision data of the three proposed spectrophotometric methods for determination of RTH in pharmaceutical dosage
forms
Proposed methods

Dosage form

Method 1

Method 2

Method 3

—
X ± SD

99.63 ± 0.23

100.22 ± 0.39

100.42 ± 0.07

RSD%

0.23

0.39

0.07

Er%

0.13

0.23

0.04

Intra day
—
X ± SD
RSD%

99.5 ± 0.4

100 ± 0.67

100.67 ± 0.14

Er%

0.4

0.67

0.14

0.23

0.39

0.08

—
X ± SD

99.77 ± 0.23

100.45 ± 0.39

100.42 ± 0.07

RSD%

0.23

0.39

0.07

Er%

0.13

0.23

0.04

Intra day
—
X ± SD

99.77 ± 0.23

100.22 ± 0.39

100.58 ± 0.14

RSD%

0.23

0.39

0.14

Er%

0.13

0.23

0.08

Inter day

Yutopar tablet
(10 mg ritodrine HCl/tab)

Inter day

Yutopar ampoule
(10 mg ritodrine HCl/amp)

RSD % = (%)/√n; Er % = error (%).
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Simplicity of the three methods is evident by the direct
measurement of the produced reaction products within
20 min. Concentrations down to 2.0, 0.2 and 0.8 µg/mL
could be measured using the three methods, proving high
sensitivity especially for method 2. These three methods could be successfully applied to the determination of
RTH in pharmaceutical dosage forms.
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